Search Results 381-390 of 11066 for total t4
Additionally, to compare the effectiveness of axicabtagene ciloleucel versus SOCT, as measured by progression-free survival (PFS) and overall survival (OS).
... complete repository of specimens from patients with thoracic disease including but not limited to suspected lung cancer, mediastinal and pleural tumors and ...
Serum Bilirubin, amylase and lipase ≤ 1.5 x ULN (in patients with known Gilbert Syndrome, total bilirubin ≤ 3 x ULN, with direct bilirubin ≤ 1.5 x ULN) ...
... total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in ...
Very low total cholesterol (less than 100 mg/dL); Secondary dyslipidemia due to diabetes mellitus or renal disease; Organ transplant and dyslipidemia ...
The primary study hypothesis is that pembrolizumab will prolong progression-free survival (PFS) or overall survival (OS) compared to current SOC chemotherapy.
... complete remission (no evidence of disease). This is an investigational ... total hysterectomy, removal of the adnexae and staging with sentinel node ...
Once this is complete treatment will be directed based on the genomic signature of patients individual tumor. ... overall study (Stage I and Stage II).
... overall survival (OS). ... * Histologically or cytologically documented ES-SCLC (American Joint Committee on Cancer, 2017, Stage IV SCLC \[T any, N any, M1 a/b/c ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.